Net profit of Shivalik Rasayan declined 35.44% to Rs 3.06 crore in the quarter ended December 2023 as against Rs 4.74 crore during the previous quarter ended December 2022. Sales rose 22.44% to Rs 70.23 crore in the quarter ended December 2023 as against Rs 57.36 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales70.2357.36 22 OPM %12.6317.40 - PBDT8.7810.37 -15 PBT5.777.42 -22 NP3.064.74 -35 Powered by Capital Market - Live News

Shivalik Rasayan will hold a meeting of the Board of Directors of the Company on 12 February 2024.Powered by Capital Market - Live News

Shivalik Rasayan announced that Dr. Vinod Kumar Singh has been appointed as Vice President in R&D Centre, Bhiwadi w.e.f. 11 January 2024. Powered by Capital Market - Live News

Shivalik Rasayan (SRL) has received Certificate of Suitability for PIRFENIDONE from European Directorate for the quality of Medicine & Healthcare. Powered by Capital Market - Live News

Net profit of Shivalik Rasayan declined 66.00% to Rs 1.88 crore in the quarter ended September 2023 as against Rs 5.53 crore during the previous quarter ended September 2022. Sales rose 19.03% to Rs 67.05 crore in the quarter ended September 2023 as against Rs 56.33 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales67.0556.33 19 OPM %14.4119.55 - PBDT8.2610.98 -25 PBT4.818.15 -41 NP1.885.53 -66 Powered by Capital Market - Live News